IGC Pharma (IGC) Shareholder's Equity Growth (3y) (2014 - 2026)
IGC Pharma (IGC) Shareholder's Equity Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
IGC Pharma |
28.11 Mn |
27.85 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-25.68% |
| Dec 31, 2025 |
-26.00% |
| Sep 30, 2025 |
-26.21% |
| Jun 30, 2025 |
-34.91% |
| Mar 31, 2025 |
-35.77% |
| Dec 31, 2024 |
-40.34% |
| Sep 30, 2024 |
-38.20% |
| Jun 30, 2024 |
-37.15% |
| Mar 31, 2024 |
-39.34% |
| Dec 31, 2023 |
-25.02% |
| Sep 30, 2023 |
-15.78% |
| Jun 30, 2023 |
-19.02% |
| Mar 31, 2023 |
-17.48% |
| Dec 31, 2022 |
-14.96% |
| Sep 30, 2022 |
-13.61% |
| Jun 30, 2022 |
-12.07% |
| Mar 31, 2022 |
-10.72% |
| Dec 31, 2021 |
-6.93% |
| Sep 30, 2021 |
31.31% |
| Jun 30, 2021 |
61.20% |
